Faculty of Pharmaceutical Sciences is where great minds make a difference. The Faculty enjoys an international reputation for outstanding pharmaceutical sciences research. Across a broad base of collaborative, paradigm-shaping pilot projects, our world-leading researchers generate relevant results that address the pressing health needs of society. In short, our work improves lives.

If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.

We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes. 

Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty includes Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.

Purpose

We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.

Commitments

  • We support our people, creating a community that enables excellence through collective action.
  • We seek novel ideas, putting into practice those with the greatest scope for sustained impact.
  • We search for relevant connections, fostering meaningful collaborations that provide mutual benefit.
 

Research Centres

adMare BioInnovations is located in our building. It is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with adMare BioInnovations to provide unique research and mentoring opportunities for MSc and PhD students. 

We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.

Research Facilities

Opened in 2012, the Pharmaceutical Sciences Building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.

Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence. 

Research Highlights

As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.

Epidemiology & Health Outcomes

This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.

Molecular & Systems Pharmacology

This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.

Nanomedicine & Chemical Biology

This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.

Pharmacy Education

Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.

Explore Research Themes

Research Supervisors in Faculty

Name Research Interests
Cairns, Brian Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders
Chang, Thomas Pharmacology and pharmaceutical sciences (except clinical aspects)
Cheng, Miffy nanomedicine; gene therapy to combat chronic diseases
Conklin, Annalijn Public health nutrition policy; Other basic medicine and life sciences; Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; women's health; Health Equity; Chronic Diseases in Elderly; Obesity; CVD risk factors; healthy ageing; food and nutrition policy; Indigenous health; Community Health / Public Health; disease management evaluation; healthcare quality improvement
Coughtrie, Michael Drug metabolizing enzymes
Cragg, Jacquelyn Epidemiology (except nutritional and veterinary epidemiology); data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease
De Vera, Mary examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.
Finbloom, Joel Drug discovery, design and delivery; Biologically active molecules; Nanochemistry; Antimicrobial resistance; Nanomedicine; nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance
Frankel, Adam Other basic medicine and life sciences; Enzymes (including kinetics and mechanisms, and biocatalyst); Protein Biochemistry; arginine methylation; Histones; Nucleosomes; post-translational modifications; Biological and Biochemical Mechanisms; Organic Molecules and Biomolecules; Bioactive Molecules; Proteins; Chemical Biology; drug discovery; Target Engagement; yeast; Amino acids
Giaever, Guri Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation
Harrison, Mark measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered
Jarvis-Selinger, Sandra Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology
Johnson, Kate Health care effectiveness and outcomes; Health economics; Health outcomes; Epidemiology
Krentz, Nicole Human development and organogenesis; Pharmacology and pharmaceutical sciences, n.e.c.; Human physiology, n.e.c.; Diabetes; Developmental biology; Genetics
Kumar, Ujendra Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs
Lalji, Fawziah Epidemiology (except nutritional and veterinary epidemiology); Pharmacoepidemiology; Infectious diseases; Immunization; Antibiotics and Resistance; Vaccine preventable diseases
Li, Shyh-Dar Drug discovery, design and delivery; Nano-technology; biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy
Loewen, Peter Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; Population health interventions; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making
Lynd, Larry health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases
Maharaj, Anil Pharmacology and pharmaceutical sciences, n.e.c.; Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology
McCormack, James Knowledge translation and evidence-based practice
Nislow, Corey Genomics; Mechanisms of carcinogenesis; genomics; Genetics; drug discovery; Biotechnology; Space Biology
Page, Brent Drug discovery, design and delivery; Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; Drug Discovery, Design and Delivery; Medicinal Chemistry; Target Engagement
Rodrigues, Brian Pharmacology and pharmaceutical sciences (except clinical aspects); Diabetes; Cardiomyopathy; Heart Failure; Energy Metabolism; Cardiovascular metabolism; Endothelial cell - cardiomyocyte crosstalk; Vascular Endothelial Growth factors
Ross, Colin Care; Genomics; Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); Biomedical Technologies; Drug Metabolism; Gene Therapy; Gene-based therapeutics; Pharmacogenomics; Precision Medicine; transgenic models

Pages

Recent Publications

This is an incomplete sample of recent publications in chronological order by UBC faculty members with a primary appointment in the Faculty of Pharmaceutical Sciences.

 

Publication: World Allergy Organization Journal
UBC Author(s): Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 18
Publication Date: July 2025

View Publication
Publication: Pediatric Blood and Cancer
UBC Author(s): Colin Ross (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 15455009
Volume: 72
Publication Date: June 2025

View Publication
Publication: Arthritis Care and Research
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Mary De Vera (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 2151464X
Volume: 77
Page Range: 801-810
Publication Date: June 2025

View Publication
Publication: Journal of Genetic Counseling
UBC Author(s): Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 10597700
Volume: 34
Publication Date: June 2025

View Publication
Publication: Nutrition Reviews
UBC Author(s): Annalijn Conklin (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00296643
Volume: 83
Page Range: 1047-1060
Publication Date: 1 June 2025

View Publication
Publication: PharmacoEconomics
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 11707690
Volume: 43
Page Range: 629
Publication Date: June 2025

View Publication
Publication: PharmacoEconomics
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 11707690
Volume: 43
Page Range: 617-627
Publication Date: June 2025

View Publication
Publication: Drug Metabolism and Disposition
UBC Author(s): Thomas Velenosi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00909556
Volume: 53
Publication Date: June 2025

View Publication
Publication: Journal of Medicinal Chemistry
UBC Author(s): Brent Page (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00222623
Volume: 68
Page Range: 9501-9524
Publication Date: 8 May 2025

View Publication
Publication: Acta Obstetricia et Gynecologica Scandinavica
UBC Author(s): Laura Schummers (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00016349
Volume: 104
Page Range: 839-849
Publication Date: May 2025

View Publication
Publication: Clinical and Translational Science
UBC Author(s): Anil Maharaj (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 17528054
Volume: 18
Publication Date: May 2025

View Publication
Publication: Applied Health Economics and Health Policy
UBC Author(s): Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 11755652
Volume: 23
Page Range: 441-452
Publication Date: May 2025

View Publication
Publication: Gene Therapy
UBC Author(s): Colin Ross (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 09697128
Volume: 32
Page Range: 197-210
Publication Date: May 2025

View Publication
Publication: Nature
UBC Author(s): Nicole Krentz (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00280836
Volume: 641
Page Range: 192-201
Publication Date: 1 May 2025

View Publication
Publication: Health Policy
UBC Author(s): Mary De Vera (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 01688510
Volume: 155
Publication Date: May 2025

View Publication
Publication: European Journal of Human Genetics
UBC Author(s): Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 10184813
Volume: 33
Page Range: 633-641
Publication Date: May 2025

View Publication
Publication: European Journal of Human Genetics
UBC Author(s): Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 10184813
Volume: 33
Page Range: 649-657
Publication Date: May 2025

View Publication
Publication: Canadian Pharmacists Journal
UBC Author(s): Kerry Wilbur (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 17151635
Volume: 158
Page Range: 172-179
Publication Date: May 2025

View Publication
Publication: JACCP Journal of the American College of Clinical Pharmacy
UBC Author(s): Ricky Turgeon (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 8
Page Range: 347-357
Publication Date: May 2025

View Publication
Publication: BMJ open
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 15
Page Range: e089693
Publication Date: 25 April 2025

View Publication
Publication: CMAJ. Canadian Medical Association Journal
UBC Author(s): Laura Schummers (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 08203946
Volume: 197
Page Range: E345-E354
Publication Date: 7 April 2025

View Publication
Publication: Medical Decision Making
UBC Author(s): Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 0272989X
Volume: 45
Page Range: 232-244
Publication Date: April 2025

View Publication
Publication: JAMA network open
UBC Author(s): Laura Schummers (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 8
Page Range: e254516
Publication Date: 1 April 2025

View Publication
Publication: BMJ Oncology
UBC Author(s): Mary De Vera (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 4
Publication Date: 1 April 2025

View Publication
Publication: Therapeutic Drug Monitoring
UBC Author(s): Colin Ross (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 01634356
Volume: 47
Page Range: 211-247
Publication Date: 1 April 2025

View Publication

Pages

Recent Thesis Submissions

Doctoral Citations

A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.
Year Citation Program
2025 In Dr. Oveisi's research, a multi-method approach was used to examine cancer’s impact on adolescent and young adult sexual and reproductive health. Quantitative analysis showed higher risks of early menopause, painful sex, and infertility. Qualitatively, patients discussed impacts on personal, relationship, and community levels, and barriers to receiving appropriate care. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2025 Dr. Thiombane used chemogenomic CRISPR screens to study a class of widely used cancer chemotherapeutic drugs named anthracyclines. Her research provided a global view of all the drug-gene interactions for several clinically used anthracyclines. Her data supports the renewed interest in the clinical use of aclarubicin for cancer chemotherapy. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Rowley studied protein arginine N-methyltransferase 2 (PRMT2), an enzyme found to be dysregulated in disease. He developed new techniques to study PRMT2 and how it interacts with other proteins. Findings from his research suggest that PRMT2 orchestrates the activities of other methyltransferases. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Lee explored heparanase’s role in providing heart energy and its changes in diabetes. He also found that heparanase overexpression led to development of physiological cardiac hypertrophy, however, its actions are negated during diabetes, resulting in heart failure. Further investigation may enhance the management of diabetic heart disease. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Rebić used nationally representative data to generate policy-relevant information on the Canadian burden of medication non-adherence, individual and healthcare system factors increasing the risk for ineffective care, and the impact of sex and gender-related inequities. Her thesis provides real-world evidence for universal Pharmacare in Canada. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Tafech's research focused on advancing gene therapies for cystic fibrosis, the most common fatal genetic disorder affecting Canadian children and young adults. His work identified nano-based strategies that significantly enhanced CRISPR-mRNA delivery and gene editing in CF, driving promising progress in this disease and other genetic disorders. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Iliev's work focused on the development of new cancer therapies. It included the design, synthesis and testing of experimental inhibitors, pushing the boundaries of traditional medicinal chemistry approaches. His top bioactive compounds will proceed to more advanced testing towards becoming next-generation cancer therapeutics. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Lee developed a decision-analytic model for evaluating long-term benefits of early interventions for asthma at the population level. He generated key evidence on the disease course of asthma and demonstrated the utility of this model by showing far-reaching benefits of reducing unnecessary infant antibiotic exposure on the burden of asthma. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Vo examined racial disparity in health outcomes and healthcare participation. He found that racialized individuals experience inadequate pain management, and are less likely to participate in health research due to distrust. These findings highlight the impact of structural racism on healthcare access and stress the urgent need for systemic changes to achieve health equity. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2024 Dr. Soukhtehzari studied glycobiology of breast cancer and identified two novel polysialylated proteins that contributed in breast cancer progression and studied their function and roles in metastasis and breast cancer patients prognosis. Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Pages